J. Molner

**J. Molner** is a Tallinn, Estonia-based pharmaceutical startup founded in 2015. The company operates as a comprehensive generic CDRO, specializing in topical, liquid, and sterile dosage forms. Their services encompass formulation chemistry, analytical methods development, and stability services, underpinned by a team of highly educated and experienced scientists. **J. Molner** focuses on core service offerings such as IVRT for semi-solid bioequivalence, Post Approval Change Management of existing or shelved applications, analytical chemistry, and drug development. Notably, the company is EU-GMP release capable and holds an MRA with the FDA, showcasing its commitment to regulatory compliance and quality standards. With a strong emphasis on IVRT testing and post-approval change management, **J. Molner** presents a compelling value proposition to pharmaceutical companies seeking to enhance their product development and regulatory processes. The company's slogan, "When you need formulation chemistry, analytical methods developed, or stability services, we're your chemistry people," underscores its commitment to being a reliable and capable partner for pharmaceutical development needs. While specific details regarding recent investments and investors are not available, the entrepreneurial spirit and the focus on critical pharmaceutical services position **J. Molner** as a potential candidate for investment consideration in the pharmaceutical industry. As **J. Molner** continues to expand its capabilities and solidify its position in the market, it could present an attractive opportunity for investors seeking to tap into the pharmaceutical sector's growth potential.